BIS icon

ProShares UltraShort NASDAQ Biotechnology
BIS

Overview Fund Trends Analyst Outlook Journalist POV

9 hedge funds and large institutions have $16.2M invested in ProShares UltraShort NASDAQ Biotechnology in 2014 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more capital invested

Capital invested by funds: $ → $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less funds holding

Funds holding: →

50% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 10

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
9
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$3.26M
Puts
$428K
Net Calls
Net Calls Change

Top Buyers

1
+$8.67M
2
+$1.36M
3
+$225K
4
VKH
Virtu KCG Holdings
New York
+$215K
5
Citadel Advisors
Citadel Advisors
Florida
+$195K

Top Sellers

1
-$2.41M
2
-$1.71M
3
-$1.07M
4
Jane Street
Jane Street
New York
-$774K
5
BMO
Beck Mack & Oliver
New York
-$602K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$14M
2
$1.36M
3
$225K
4
$215K
5
$195K
6
$108K
7
$46K
8
$27K
9
$16K
10
–
11
–
12
–
13
–
14
–
15
–
16
–
17
–
18
–
19
–